Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The FEBS Journal|October 7, 2009
LRRK2 in Parkinson's disease: function in cells and neurodegenerationPhilip J Webber, Andrew B WestThe Journal of Biological Chemistry|October 15, 2009
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerizationSaurabh Sen, Philip J Webber, Andrew B WestPlos Genetics|February 25, 2012
GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1Klodjan Stafa, Alzbeta Trancikova, Philip J Webber, et al.Oncoscience|October 27, 2015
Combination of heat shock protein 90 and focal adhesion kinase inhibitors synergistically inhibits the growth of non-small cell lung cancer cellsPhilip J Webber, Chanhee Park, Min Qui, et al.Journal of Molecular Biology|August 3, 2011
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activitiesPhilip J Webber, Archer D Smith, Saurabh Sen, et al.Plos One|October 20, 2012
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutationsAlzbeta Trancikova, Adamantios Mamais, Philip J Webber, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 4, 2012
LRRK2 inhibition attenuates microglial inflammatory responsesMark S Moehle, Philip J Webber, Tonia Tse, et al.Plos One|October 7, 2009
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegenerationKim A Caldwell, Michelle L Tucci, Jafa Armagost, et al.Human Molecular Genetics|July 27, 2013
LRRK2 secretion in exosomes is regulated by 14-3-3Kyle B Fraser, Mark S Moehle, João P L Daher, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseJan O Aasly, Carles Vilariño-Güell, Justus C Dachsel, et al.Pageof 2